Trump Media’s stock has plunged to historic lows, erasing billions in value and raising urgent questions about the future of ...

B. Riley upwardly revised its price target on Oklo stock. Oklo signed a memorandum of understanding with Battelle Energy Alliance. Investors with low risk tolerances will want to avoid Oklo stock at ...

The consensus among Wall Street analysts says that, among the 10 stocks with trillion-dollar valuations, Meta Platforms is the most undervalued. Meta is using artificial intelligence to boost ...

Energy Transfer is a North American midstream giant. It's largely a toll-taker business that supports a lofty distribution yield of around 8%.. Before you rely on Energy Transfer's yield to pay your ...

With AT&T Inc. shares off about 14% from their 2025 highs, KeyBanc’s Brandon Nispel sees a buying opportunity. He upgraded the telecommunications stock to overweight from sector-weight late on Tuesday ...

Shares of Alibaba Group Holding Limited American (NASDAQ: BABA) are falling after a report alleged that the ecommerce company worked with the Chinese military to target the US. What To Know: Alibaba ...

Stock Market on Nov. 14, 2025: Dow ends lower, S&P 500 slips in choppy trading session; Nasdaq rises as tech stocks advance; S&P 500 ekes out weekly gain Major U.S. stock indexes finished mostly lower ...

What To Know: The sell-off was triggered by the company’s Nov. 5 third-quarter earnings report, where the luxury EV maker posted an adjusted loss of $2.65 per share, wider than the consensus estimate ...

Stocks were rising to start the month of November, as strong earnings continued to propel the major indexes. The S&P 500 was up 0.5%. The Dow Jones Industrial Average was up 14 points, or essentially ...

Novo Nordisk NOVO.B-0.23%decrease; red down pointing triangle shares rose Monday after the Danish drugmaker withdrew from a bidding war with Pfizer for U.S. obesity drug maker Metsera. Shares climbed ...

Novo Nordisk NOVO.B2.33%increase; green up pointing triangle shares rose Monday after the Danish drugmaker withdrew from a bidding war with Pfizer for U.S. obesity drug maker Metsera ...